Search images on Google      Product Monograph

Active Ingredients:

• ustekinumab, 5 MG/ML

DIN: 02544210

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: VIAL

Schedule: Prescription

Company: AMGEN CANADA INC

ATC:

• L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
• L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
• L04AC - Interleukin inhibitors (ATC, WHO)
• L04AC05 - USTEKINUMAB (WHO)

Reference brand drug: Stelara

 

External Links for Wezlana I.v.:

Search on Google

• Wezlana I.v. side effects
• Wezlana I.v. dosage
• ustekinumab side effects
• ustekinumab dosage